Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jin Yufu ointment (also known as Yufu cream or Barnak Jin Yufu Ointment) is a traditional Chinese medicine-based topical ointment developed by China's Maybuck Group (also known as Buck Company). It is formulated with natural botanical extracts and traditional ingredients, including saffron (Crocus sativus), Coptis chinensis, Amur cork tree bark (Phellodendron amurense), Scutellaria baicalensis, pearl, yellow vaseline, lanolin, glycerin, and tea oil. It is primarily used for wound healing, skin regeneration, and antibacterial protection, particularly in refractory wounds, burns, scalds, diabetic foot ulcers, and extensive exfoliative skin lesions (such as those occurring after hematopoietic stem cell transplantation). The ointment promotes tissue regeneration, reduces inflammation, and accelerates wound healing without significant scarring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jin Yufu ointment.